Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-10

Clinical Trial Update: Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma

View source ↗

Summary

A completed study assessed whether specific vitamin D receptor polymorphisms (ApaI and Tru9I) are linked to the risk of primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lv Yingjuan | Conditions: Primary Open- Angle Glaucoma | Status: COMPLETED